ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,848
Diagnostic referrals
1,097
Outstanding pathways
372

Screening pathway

  1. Screening5,848Encounters
  2. Positive finding2,091Documented findings
  3. Referral1,097Diagnostic referrals
  4. Follow-up1,284Diagnostic visits
  5. Outcome725Resolved pathways

Stage totals use different units. Pending pathways: 285. Insufficient observation: 87.

Participant insight

Expanded synthetic participant 0053 · EXP-0053Synthetic · Site A

Full participant history through 2028-05-05, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2027-06-01
  4. · Diagnostic referral · EXP-0053-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Contact difficulty
  8. · Barrier documented · Transport difficulty
  9. · Navigation intervention · Coordination support
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2028-01-23
  14. · Follow-up disposition · Resolved · EXP-0053-T-R
  15. · Screening · HPV DNA · Repeat · Prior VIA positive
  16. · Screening result · HPV DNA · HPV not detected · Adequate
  17. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  18. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0428 · Expanded synthetic participant 0428Site E — Resource-Constrained Navigation Programme
EXP-0429 · Expanded synthetic participant 0429Site E — Resource-Constrained Navigation Programme
EXP-0430 · Expanded synthetic participant 0430Site B — Peri-Urban Access Programme
EXP-0431 · Expanded synthetic participant 0431Site A — Urban Referral Hub
EXP-0433 · Expanded synthetic participant 0433Site B — Peri-Urban Access Programme
EXP-0434 · Expanded synthetic participant 0434Site B — Peri-Urban Access Programme
EXP-0435 · Expanded synthetic participant 0435Site D — Community Engagement Programme
EXP-0436 · Expanded synthetic participant 0436Site D — Community Engagement Programme
EXP-0437 · Expanded synthetic participant 0437Site E — Resource-Constrained Navigation Programme
EXP-0438 · Expanded synthetic participant 0438Site C — Rural Outreach Programme
EXP-0439 · Expanded synthetic participant 0439Site A — Urban Referral Hub
EXP-0440 · Expanded synthetic participant 0440Site E — Resource-Constrained Navigation Programme
EXP-0441 · Expanded synthetic participant 0441Site B — Peri-Urban Access Programme
EXP-0442 · Expanded synthetic participant 0442Site C — Rural Outreach Programme
EXP-0443 · Expanded synthetic participant 0443Site C — Rural Outreach Programme
EXP-0444 · Expanded synthetic participant 0444Site B — Peri-Urban Access Programme
EXP-0445 · Expanded synthetic participant 0445Site E — Resource-Constrained Navigation Programme
EXP-0446 · Expanded synthetic participant 0446Site B — Peri-Urban Access Programme
EXP-0447 · Expanded synthetic participant 0447Site C — Rural Outreach Programme
EXP-0448 · Expanded synthetic participant 0448Site E — Resource-Constrained Navigation Programme
EXP-0449 · Expanded synthetic participant 0449Site E — Resource-Constrained Navigation Programme
EXP-0450 · Expanded synthetic participant 0450Site A — Urban Referral Hub
EXP-0451 · Expanded synthetic participant 0451Site A — Urban Referral Hub
EXP-0452 · Expanded synthetic participant 0452Site B — Peri-Urban Access Programme
EXP-0453 · Expanded synthetic participant 0453Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1970
HPV DNA
3151
Cytology
727

Navigation activity

Barrier documented
937
Contact attempt
1505
Navigation intervention
417
Diagnostic booking
1301
Diagnostic visit
1284

Documented barriers

Contact difficulty
298
Transport difficulty
311
Appointment coordination
328

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.